Slide 1: A stable first quarter – while we shape the future Arjo
ARJO Q1 REPORT 2026 A stable first quarter – while we shape the future Arjo Andréas Elgaard, President and CEO Christofer Carlsson, CFO
Slide 2: We exist for the most vulnerable moments in care
We exist for the most vulnerable moments in care. Our solutions empower movement while protecting caregivers and enabling safer, more efficient care.
Slide 3: Experts in improving mobility in acute care and long-term care settings
Experts in improving mobility in acute care and long-term care settings Patient handling Hygiene and wellness Wide range of lifts, slings, Ergonomic, adaptable bathing lateral transfer and repositioning and showering systems for all levels of mobility aids, to enable mobilisation early, often and re
Slide 4: Q1 2026 summary
Q1 2026 summary Andréas Elgaard President and CEO
Slide 5: Q1 2026 Key Takeaways
Q1 2026 KEY TAKEAWAYS Solid growth in Q1 • Organic revenue growth of 3.8% driven by continued positive trend in US capital and strong sales in RoW Net sales Gross organic growth margin • Gross margin slightly below last year due to unfavorable product mix as well as currency and US tariffs – price a
Slide 6: North America and Global Sales
2.2% 4.4% North America Global Sales Healthy demand in the US Western Europe, -2.9% • Continued strong momentum in • Solid growth in large markets Patient handling like France and Italy • Somewhat weaker rental season • UK market conditions remain challenging Canada slightly below versus Rest of the
Slide 7: Modernizing 36 healthcare facilities in South Africa
Q1 2026 KEY TAKEAWAYS “We’re helping create better conditions for both patients Modernizing 36 healthcare and caregivers” facilities in South Africa Karin Heijboer, Arjo Africa • Introducing modern, consistent equipment helps improve safety for caregivers, enhance patient comfort, and bring greater
Slide 8: Financial performance Q1 2026
Financial performance Q1 2026 Christofer Carlsson CFO
Slide 9: Margin impacted by unfavorable mix effects and US tariffs
Q1 2026 GROSS PROFIT Margin impacted by unfavorable mix effects and US tariffs Gross profit bridge – Q1 2026 vs. Q1 2025 (MSEK) Margin development • Patient handling and Diagnostics contributing positively x Margin (Percent) x (Percentage point) • Unfavorable mix effects from product and geography 4
Slide 10: Adjusted EBIT in line with last year when excluding currency and tariffs
Q1 2026 ADJUSTED EBIT Adjusted EBIT in line with last year when excluding currency and tariffs Adj. EBIT bridge – Q1 2026 vs. Q1 2025 (MSEK) x Margin (Percent) • Underlying profitability in line with last year when adjusted for currency and tariffs 7.3% 7.1% • US tariffs effect -10 MSEK -30 6 -29 37
Slide 11: Seasonal effect brings working capital days up slightly, while operating cash flow improved
Seasonal effect brings working capital days up slightly, while operating cash flow improved y-o-y Working capital days Operating cash flow (MSEK) 734 600 565 96 95 512 479 86 437 446 82 84 83 82 83 79 78 81 77 76 344 250 256 237 184 205 Q1.23 Q2.23 Q3.23 Q4.23 Q1.24 Q2.24 Q3.24 Q4.24 Q1.25 Q2.25 Q3.
Slide 12: Continued net debt decrease and leverage flat vs. Q4
Continued net debt decrease and leverage flat vs. Q4 Net debt Leverage Net debt, incl. IFRS16 (BSEK) Net debt / Adj EBITDA, multiple (R12)* 5.3 5.2 2.8 2.8 4.7 2.6 4.7 2.4 4.5 4.5 2.3 2.3 4.3 4.4 4.4 4.3 4.3 2.3 2.2 2.2 2.2 2.2 4.2 4.1 2.0 2.1 Q1.23 Q2.23 Q3.23 Q4.23 Q1.24 Q2.24 Q3.24 Q4.24 Q1.25 Q2
Slide 13: Shaping the future Arjo
Shaping the future Arjo Andréas Elgaard President and CEO
Slide 14: Unlocking untapped potential – strategy work ongoing
Unlocking untapped potential – strategy work ongoing • New strategy under development together with leaders across the organization to ensure alignment, accountability and strong execution • Shaping a clear long-term strategic direction to develop a more focused, robust and profitable Arjo • Improvi
Slide 15: Q&A
Q&A glels
Slide 16: Financial calendar and further questions
Financial calendar Annual General Meeting 2026 April 22, 2026 Interim Report Jan-Jun 2026 July 14, 2026 Interim Report Jan-Sep 2026 October 22, 2026 Further questions Maria Nilsson EVP, Communication & Public Relations +46 734 244 515 maria.nilsson@arjo.com Erik Roslund Investor Relations & Corporat
Slide 17: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of Arjo’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectations will
Slide 18: Empowering movement
aifJjJoO EMPOWERING MOVEMENT